Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
80.18
+1.39 (1.77%)
Jun 22, 2026, 9:36 AM EDT - Market open
Cytokinetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $102 | Buy | Maintains | $102 | +27.22% | Jun 16, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $97 | Buy | Maintains | $97 | +20.99% | Jun 5, 2026 |
| Citi | Citi | Buy Initiates $99 | Buy | Initiates | $99 | +23.48% | May 18, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $103 | Buy | Maintains | $103 | +28.47% | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $140 | Buy | Reiterates | $140 | +74.62% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | +30.96% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $98 → $108 | Buy | Reiterates | $98 → $108 | +34.71% | May 7, 2026 |
Unknown Analyst Raymond James No rating | Raymond James | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.